It took two years to receive an ALS diagnosis. ALS is a nervous system disease that can cause loss of muscle control and ...

The pathway leading to the telltale sign of ALS, protein aggregation in the cytoplasm of motor neurons, has been revealed.

Trace Neuroscience aims to advance an RNA-binding therapy designed to preserve — and potentially improve — muscle function in ...

Sandra Abrevaya and her husband Brian Wallach started Synpaticure to help patients with neurodegenerative diseases access ...

A trial participant who’d received the shot in Jan. 2023 later developed motor neuropathy, or muscle weakness, leading the ...

The test’s ability to distinguish ALS from similar conditions is particularly noteworthy. It could help physicians differentiate between ALS and conditions that mimic its symptoms, such as primary ...

Advancement of Fast Skeletal Muscle Troponin Activator Expands Pipeline of Muscle-Directed Drug Candidates SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Na ...

The funds will help local families who are personally impacted by the disease. ALS attacks the nervous system and its nerve ...

Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years after being diagnosed, according to the Centers for ...

Researchers have uncovered a mechanism that may trigger ALS’s earliest stages, identifying proteins that mislocalize, causing ...

Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for ...